These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 152559)

  • 21. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down's syndrome.
    Morinushi T; Lopatin DE; Van Poperin N
    J Periodontol; 1997 Jul; 68(7):626-31. PubMed ID: 9249633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leucocyte ultrastructure and folate metabolism in Down's syndrome.
    Gericke GS; Hesseling PB; Brink S; Tiedt FC
    S Afr Med J; 1977 Mar; 51(12):369-74. PubMed ID: 139696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels.
    Kanavin O; Scott H; Fausa O; Ek J; Gaarder PI; Brandtzaeg P
    Acta Med Scand; 1988; 224(5):473-7. PubMed ID: 2974234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
    Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
    Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T lymphocytes in patients with Down's syndrome.
    Wisniewski K; Cobill JM; Wilcox CB; Caspary EA; Williams DG; Wisniewski HM
    Biol Psychiatry; 1979 Jun; 14(3):463-71. PubMed ID: 157786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome.
    Loh RK; Harth SC; Thong YH; Ferrante A
    Pediatr Infect Dis J; 1990 Aug; 9(8):547-51. PubMed ID: 2146585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis.
    Meyerovitch J; Antebi F; Greenberg-Dotan S; Bar-Tal O; Hochberg Z
    Arch Dis Child; 2012 Jul; 97(7):595-8. PubMed ID: 22535238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunodeficiency in Down's syndrome: analysis by OKT monoclonal antibodies.
    Bertotto A; Gerli R; Fabietti G; Arcangeli CD; Bianchi S; Vaccaro R
    Thymus; 1984; 6(6):365-7. PubMed ID: 6084348
    [No Abstract]   [Full Text] [Related]  

  • 33. Down's syndrome is a risk factor for severe lower respiratory tract infection due to respiratory syncytial virus.
    Galleguillos C; Galleguillos B; Larios G; Menchaca G; Bont L; Castro-Rodriguez JA
    Acta Paediatr; 2016 Nov; 105(11):e531-e535. PubMed ID: 27537430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal impairment in urate excretion in patients with Down's syndrome.
    Nishida Y; Akaoka I; Kobayashi M; Maruki K; Oshima Y
    J Rheumatol; 1979; 6(1):103-7. PubMed ID: 155745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody-defined B cell subsets in aging humans and Down's syndrome.
    Gupta S; Zola H; Brooks DA; Bradley J; Fikrig SM; Mariano E; Quazi Q
    Gerontology; 1984; 30(6):388-92. PubMed ID: 6240431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome.
    Mori M; Morio T; Ito S; Morimoto A; Ota S; Mizuta K; Iwata T; Hara T; Saji T
    J Infect Chemother; 2014 Aug; 20(8):455-9. PubMed ID: 24929631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid antibodies and Australia antigen in Down's syndrome.
    Fialkow PJ; Blumberg BS; London WT; Sutnick AI; Thuline HC
    J Ment Defic Res; 1971 Sep; 15(3):177-80. PubMed ID: 4255524
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunodeficiency in Down's syndrome: low levels of serum thymic factor in trisomic children.
    Duse M; Brugo MA; Martini A; Tassi C; Ferrario C; Ugazio AG
    Thymus; 1980 Dec; 2(3):127-31. PubMed ID: 6451065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olfactory function in young adolescents with Down's syndrome.
    McKeown DA; Doty RL; Perl DP; Frye RE; Simms I; Mester A
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):412-4. PubMed ID: 8890783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.